Hepatectomy After Conversion Therapy Using Tyrosine Kinase Inhibitors Plus Anti-PD-1 Antibody Therapy for Patients with Unresectable Hepatocellular Carcinoma.

Ann Surg Oncol · 2023 · PMC10085942 · PMID 36178565

Europe PMC DOI

hedged sentence

0.1870

closest p · 3.7× alpha

0.1870

boldest claim

The sentences

a trend toward significanceP = 0.187not close (p > 0.1)

Achieving a pathologic complete response ( n = 10) to systemic therapy was associated with a favorable recurrence-free survival after resection, with a trend toward significance (HR, 0.345; 95% CI, 0.067–1.785; P = 0.187).

also in 3,729 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.